HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuelian Zhang Selected Research

notoginsenoside R1

2/2020Correction: Zhou, P., et al. Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy. Cells, 2019, 8, 213.
1/2019Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression.
1/2019Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy.
1/2018Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuelian Zhang Research Topics

Disease

11Tuberculosis (Tuberculoses)
01/2020 - 09/2005
9Infections
04/2022 - 02/2012
7Inflammation (Inflammations)
01/2022 - 06/2015
7Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2014
6Obesity
01/2022 - 06/2016
6Neoplasms (Cancer)
01/2021 - 07/2007
4Insulin Resistance
01/2022 - 01/2018
3Body Weight (Weight, Body)
01/2022 - 11/2018
3Diabetic Cardiomyopathies
01/2022 - 01/2018
3Diabetic Nephropathies (Diabetic Nephropathy)
11/2021 - 01/2019
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2020 - 01/2019
3Myocardial Infarction
12/2017 - 08/2010
2Hyperglycemia
01/2022 - 12/2018
2Heart Diseases (Heart Disease)
01/2022 - 12/2010
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2021
2Hypoxia (Hypoxemia)
01/2020 - 06/2018
2Chemical and Drug Induced Liver Injury
05/2019 - 04/2019
2Infarction (Infarctions)
12/2010 - 08/2010
2Neurofibroma
10/2010 - 07/2007
1Hypoproteinemia
04/2022
1Coma (Comas)
04/2022
1Traumatic Brain Injuries (Traumatic Brain Injury)
04/2022
1Fibrosis (Cirrhosis)
01/2022
1Diabetes Complications
01/2022
1Erythema
01/2022
1Hypertrophy
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Chronic Hepatitis B
09/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Hypophosphatasia
12/2020
1Alcoholic Fatty Liver
03/2020
1Non-alcoholic Fatty Liver Disease
03/2020
1Weight Loss (Weight Reduction)
01/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2020
1Tetanus
07/2019
1Colorectal Neoplasms (Colorectal Cancer)
06/2019
1Headache (Headaches)
05/2019
1Fever (Fevers)
05/2019
1Bacterial Infections (Bacterial Infection)
04/2019
1hypoglycemic encephalopathy
01/2019

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
04/2022 - 09/2008
9Pharmaceutical PreparationsIBA
05/2019 - 01/2010
7LipidsIBA
01/2022 - 01/2015
4SaponinsIBA
01/2022 - 11/2018
4notoginsenoside R1IBA
02/2020 - 01/2018
3AdipokinesIBA
01/2022 - 05/2021
3Insulin (Novolin)FDA Link
01/2022 - 06/2016
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
06/2018 - 04/2014
2ginsenoside Rb1IBA
01/2022 - 11/2018
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 08/2017
2Blood Glucose (Blood Sugar)IBA
01/2022 - 11/2021
2Antiviral Agents (Antivirals)IBA
09/2021 - 01/2018
2Biological ProductsIBA
01/2021 - 01/2012
2Retinaldehyde (Retinal)IBA
01/2020 - 01/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2019
2Estrogen ReceptorsIBA
01/2018 - 07/2007
2Biomarkers (Surrogate Marker)IBA
07/2017 - 02/2012
2AntigensIBA
07/2017 - 02/2012
2MicroRNAs (MicroRNA)IBA
10/2016 - 01/2012
2PyrazinamideFDA LinkGeneric
03/2015 - 09/2011
2SteroidsIBA
10/2010 - 07/2007
2Hormones (Hormone)IBA
10/2010 - 07/2007
1GinsenosidesIBA
01/2022
1Imiquimod (Aldara)FDA LinkGeneric
01/2022
1Neutralizing AntibodiesIBA
01/2022
1CateninsIBA
01/2022
1Eosine Yellowish-(YS) (Eosin)IBA
01/2022
1oren gedoku toIBA
01/2022
1Hematoxylin (Haematoxylon)IBA
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1BerberineIBA
11/2021
1Metformin (Glucophage)FDA LinkGeneric
11/2021
1Alanine Transaminase (SGPT)IBA
09/2021
1LipopolysaccharidesIBA
05/2021
1AerosolsIBA
01/2021
1N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
12/2020
1Alkaline PhosphataseIBA
12/2020
1PalmitatesIBA
03/2020
1Fatty Acids (Saturated Fatty Acids)IBA
03/2020
1Atorvastatin (Lipitor)FDA Link
03/2020
1VaccinesIBA
01/2020
1CannabinoidsIBA
01/2020
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2020
1ginsenoside ReIBA
01/2020
1Transfer RNA (tRNA)IBA
07/2019
1Polysaccharides (Glycans)IBA
06/2019
1AICA ribonucleotide (ZMP)IBA
06/2019
1Poly I-CIBA
06/2019
1Acetaminophen (Paracetamol)FDA LinkGeneric
05/2019
1Anti-Bacterial Agents (Antibiotics)IBA
04/2019

Therapy/Procedure

6Therapeutics
11/2021 - 10/2010
1Tracheostomy
04/2022
1Length of Stay
04/2022
1Nursing Care
04/2022
1Artificial Respiration (Mechanical Ventilation)
04/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022